Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Ixabepilone|DRUG: Trastuzumab|DRUG: Carboplatin
Sponsor: SCRI Development Innovations, LLC
Collaborators: Bristol-Myers Squibb|Genentech, Inc.